Sugi Predict

Sugi Predict / Compounds / SCHEMBL94489

SCHEMBL94489

SCHEMBL94489

C[N+](C)(C)CC(CC(=O)[O-])OC(=O)[C@H](O)[C@@H](O)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.61
▸ KMT2A Q03164 4/20 0.61
▸ CYP1A2 P05177 3/20 0.61
▸ HRH1 P35367 1/20 0.61
▸ CYP2C19 P33261 2/20 0.58
▸ RECQL P46063 1/20 0.58
▸ SLC25A20 O43772 3/20 0.50
▸ TP53 P04637 3/20 0.50
▸ TSHR P16473 3/20 0.50
▸ CYP2D6 P10635 2/20 0.50
▸ SLC6A5 Q9Y345 2/20 0.50
▸ MAPT P10636 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ HIF1A Q16665 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ THPO P40225 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ SLC22A16 Q86VW1 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2163305 1.00 MEN1 (0.61) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL94122 1.00 MEN1 (0.61) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL27469410 0.87 LMNA (0.60) MEN1KMT2ACYP1A2HRH1CYP2C19
Cadaverine Tartrate SCHEMBL7526527 0.87 MEN1 (0.59) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL2507637 0.86 LMNA (0.58) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL3899729 0.86 LMNA (0.58) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL27669980 0.86 LMNA (0.58) MEN1KMT2ACYP1A2HRH1CYP2C19
Zinc Ion SCHEMBL7620932 0.86 LMNA (0.58) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL17164649 0.86 MEN1 (0.63) MEN1KMT2ACYP1A2HRH1CYP2C19
Propionyl-Carnitine SCHEMBL2231499 0.85 MEN1 (0.82) MEN1KMT2ACYP1A2HRH1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025262705-A1 A FORMULATION FOR WEIGHT AND METABOLIC REGULATION SEVEN TURNS PVT. LTD. (IN) 2025-12-26 — — WO claimed
US-20250213501-A1 IMPROVING SEMEN QUALITY CEUTICS HEALTH GMBH (AT) 2025-07-03 — — US claimed
EP-4503955-A1 IMPROVING SEMEN QUALITY Ceutics Health GmbH (AT) 2025-02-12 — — EP claimed
US-20240425444-A1 PROCESS FOR PRODUCING CRYSTALLINE L-CARNITINE HUBEI XUJIE PHARMACEUTICAL CO., LTD (CN) 2024-12-26 — — US claimed
US-20240325324-A1 COMPOSITIONS AND METHODS FOR TREATING DRY EYE Genetic Disease Investigators, LLC 2024-10-03 — — US claimed
US-20240228429-A1 PROCESS FOR PRODUCING L-CARNITINE HUBEI XUJIE PHARMACEUTICAL CO., LTD (CN) 2024-07-11 — — US claimed
US-20240217920-A1 PROCESS FOR PRODUCING L-CARNITINE HUBEI XUJIE PHARMACEUTICAL CO., LTD (CN) 2024-07-04 — — US claimed
WO-2023194470-A1 IMPROVING SEMEN QUALITY THE CEUTICS COMPANY GESMBH (AT) 2023-10-12 — — WO claimed
EP-4256977-A1 IMPROVING SEMEN QUALITY The Ceutics Company GesmbH (AT) 2023-10-11 — — EP claimed
US-20220409639-A1 COMPOSITIONS AND METHODS FOR TREATING DRY EYE Genetic Disease Investigators, LLC 2022-12-29 — — US claimed
US-20040057983-A1 For thermomagnetic energy within the human body; incorporated into jewelry or patches to provide pain relief, stamina, strength; materials which are capable of thermomagnetic levororotary and/or dextrorotary action SOLETLUNA HOLDINGS, INC. 2004-03-25 — — US claimed
US-20030175403-A1 Potentiated bioactive additives and method of use GURIN MICHAEL H (US) 2003-09-18 — — US claimed
US-6608222-B2 Feed adjuvants ALPHA FOOD INGREDIENTS, INC. 2003-08-19 — — US claimed
CN-1429110-A Method for increasing intestinal absorption of fat soluble vitamins in postmenopausal women and lower animals HILL S PET NUTRITION CO (US) 2003-07-09 — — CN claimed
EP-1261330-A2 METHOD FOR INCREASING INTESTINAL ABSORPTION OF FAT SOLUBLE VITAMINS IN POST-MENOPAUSAL WOMEN AND IN LOWER ANIMALS Hill's Pet Nutrition (US) 2002-12-04 — — EP claimed
US-6476010-B2 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals HILL'S PET NUTRITION 2002-11-05 — — US claimed
US-20020147356-A1 Bioactive conjugated linoleic acid glycerides and method of use ALPHA FOODS INGREDIENTS INC. 2002-10-10 — — US claimed
US-20010041695-A1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals KANSAS STATE RESEARCH FOUNDATION 2001-11-15 — — US claimed
WO-2001068075-A2 METHOD FOR INCREASING INTESTINAL ABSORPTION OF FAT SOLUBLE VITAMINS IN POST-MENOPAUSAL WOMEN AND LOWER ANIMALS HILL'S PET NUTRITION (US) 2001-09-20 — — WO claimed
CN-1244575-A Making process of slimming health beer WANG BAIHUA (CN) 2000-02-16 — — CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240217920-A1 PROCESS FOR PRODUCING L-CARNITINE CRAT, SLC25A20, CPT2 MEN1 3564/4885KMT2A 1288/4885CYP1A2 2058/4885
US-20240228429-A1 PROCESS FOR PRODUCING L-CARNITINE CRAT, CPT1B, SLC25A20 MEN1 1910/4885KMT2A 1543/4885CYP1A2 2550/4885
US-20240425444-A1 PROCESS FOR PRODUCING CRYSTALLINE L-CARNITINE CPT1A, CRAT, CPT2 MEN1 3962/4885KMT2A 4128/4885CYP1A2 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.